FEZF1

FEZ family zinc finger 1, the group of Zinc fingers C2H2-type

Basic information

Region (hg38): 7:122301303-122310691

Previous symbols: [ "ZNF312B" ]

Links

ENSG00000128610NCBI:389549OMIM:613301HGNC:22788Uniprot:A0PJY2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hypogonadotropic hypogonadism 22 with or without anosmia (Strong), mode of inheritance: AR
  • hypogonadotropic hypogonadism 22 with or without anosmia (Moderate), mode of inheritance: AR
  • Kallmann syndrome (Supportive), mode of inheritance: AD
  • hypogonadotropic hypogonadism 22 with or without anosmia (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hypogonadotropic hypogonadism 22 with or without anosmiaAREndocrineIn Hypogonadotropic hypogonadism, surveillance in adolescence related to sexual maturation is indicated, as is monitoring of bone mineral density in order to allow early detection and treatment of disease; In order to induce and maintain secondary sex characteristics, gradually increasing doses of gonadal steroids (females: estrogen/progestin; males: testosterone/hCG) can be beneficial; Related to fertility, endocrinologic therapy (females: recombinant hCG or pulsatile GnRH therapy; males: hCG/HMG/recombinant FSH or pulsatile GnRH therapy) may be effective, though IVF may be requiredEndocrine; Neurologic25192046

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FEZF1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FEZF1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
18
clinvar
1
clinvar
19
missense
32
clinvar
5
clinvar
37
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
13
clinvar
16
clinvar
29
Total 0 0 32 36 17

Variants in FEZF1

This is a list of pathogenic ClinVar variants found in the FEZF1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-122301727-T-TA Likely benign (Nov 22, 2019)1189418
7-122302003-G-A Likely benign (Jun 23, 2023)2969458
7-122302008-C-T Inborn genetic diseases Uncertain significance (Jul 30, 2023)2602512
7-122302010-T-C Inborn genetic diseases Uncertain significance (Nov 08, 2022)2324217
7-122302028-A-C Inborn genetic diseases Uncertain significance (May 14, 2024)2175971
7-122302032-G-A Inborn genetic diseases Uncertain significance (May 13, 2024)3278552
7-122302032-G-T Inborn genetic diseases Uncertain significance (Dec 13, 2021)2266618
7-122302052-G-T Inborn genetic diseases Uncertain significance (Jul 14, 2021)2236936
7-122302075-C-T not specified • FEZF1-related disorder Benign (Mar 12, 2022)713972
7-122302076-G-A Inborn genetic diseases Uncertain significance (Sep 27, 2021)2348403
7-122302082-T-G Amenorrhea Likely benign (Dec 10, 2018)1344748
7-122302102-C-T FEZF1-related disorder Likely benign (Mar 22, 2023)2415775
7-122302107-C-G Uncertain significance (Jul 30, 2022)2020581
7-122302205-T-C Inborn genetic diseases Uncertain significance (Jun 22, 2024)3278556
7-122302239-C-T Inborn genetic diseases Uncertain significance (Dec 01, 2022)2331214
7-122302261-G-A not specified • FEZF1-related disorder Benign/Likely benign (Dec 23, 2021)741676
7-122302261-G-C Likely benign (Dec 21, 2023)1907351
7-122302301-T-G Inborn genetic diseases Uncertain significance (Mar 25, 2024)3278553
7-122302388-GA-G Benign (Oct 21, 2018)1243725
7-122302472-A-G Benign (Jun 28, 2019)1227480
7-122302567-A-G Benign (Aug 09, 2018)1269885
7-122302620-C-A Benign (Aug 09, 2018)1263455
7-122302778-G-GACA Benign (Mar 31, 2019)1246110
7-122302784-T-C Benign (Dec 12, 2023)1988604
7-122302793-G-C Benign (Jan 31, 2024)1231901

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FEZF1protein_codingprotein_codingENST00000442488 49298
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9500.0495125742061257480.0000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.292102700.7790.00001213110
Missense in Polyphen63102.020.617551263
Synonymous0.1621131150.9810.00000548957
Loss of Function3.20113.90.07226.07e-7176

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004630.0000462
European (Non-Finnish)0.00004410.0000264
Middle Eastern0.000.00
South Asian0.00006550.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcription repressor. Involved in the axonal projection and proper termination of olfactory sensory neurons (OSN). Plays a role in rostro-caudal patterning of the diencephalon and in prethalamic formation. Expression is required in OSN to cell-autonomously regulate OSN axon projections. Regulates non-cell-autonomously the layer formation of the olfactory bulb development and the interneurons. May be required for correct rostral migration of the interneuron progenitors (By similarity). {ECO:0000250}.;
Pathway
Olfactory bulb development and olfactory learning (Consensus)

Recessive Scores

pRec
0.0948

Intolerance Scores

loftool
0.395
rvis_EVS
-0.01
rvis_percentile_EVS
53.19

Haploinsufficiency Scores

pHI
0.354
hipred
Y
hipred_score
0.808
ghis
0.420

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.887

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fezf1
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; craniofacial phenotype; taste/olfaction phenotype; growth/size/body region phenotype;

Zebrafish Information Network

Gene name
fezf1
Affected structure
hypothalamus development
Phenotype tag
abnormal
Phenotype quality
disrupted

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;neuron migration;axon guidance;negative regulation of cell population proliferation;olfactory bulb development;forebrain anterior/posterior pattern specification;cell dedifferentiation;positive regulation of neuron differentiation;positive regulation of transcription, DNA-templated
Cellular component
nucleus;cytosol
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;metal ion binding